JP2006528617A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528617A5
JP2006528617A5 JP2006520897A JP2006520897A JP2006528617A5 JP 2006528617 A5 JP2006528617 A5 JP 2006528617A5 JP 2006520897 A JP2006520897 A JP 2006520897A JP 2006520897 A JP2006520897 A JP 2006520897A JP 2006528617 A5 JP2006528617 A5 JP 2006528617A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
group
optionally
aryl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006520897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528617A (ja
Filing date
Publication date
Priority claimed from GB0317346A external-priority patent/GB0317346D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/003184 external-priority patent/WO2005012263A1/en
Publication of JP2006528617A publication Critical patent/JP2006528617A/ja
Publication of JP2006528617A5 publication Critical patent/JP2006528617A5/ja
Withdrawn legal-status Critical Current

Links

JP2006520897A 2003-07-24 2004-07-23 5−ht2b受容体アンタゴニスト Withdrawn JP2006528617A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0317346A GB0317346D0 (en) 2003-07-24 2003-07-24 5-ht2b receptor antagonists
US49028603P 2003-07-28 2003-07-28
PCT/GB2004/003184 WO2005012263A1 (en) 2003-07-24 2004-07-23 5-ht2b receptor antagonists

Publications (2)

Publication Number Publication Date
JP2006528617A JP2006528617A (ja) 2006-12-21
JP2006528617A5 true JP2006528617A5 (enExample) 2007-09-06

Family

ID=34117640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006520897A Withdrawn JP2006528617A (ja) 2003-07-24 2004-07-23 5−ht2b受容体アンタゴニスト

Country Status (5)

Country Link
US (1) US20090018150A1 (enExample)
EP (1) EP1648876A1 (enExample)
JP (1) JP2006528617A (enExample)
CA (1) CA2532505A1 (enExample)
WO (1) WO2005012263A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005097113A2 (en) * 2004-04-08 2005-10-20 Pharmagene Laboratories Limited 5-ht2b receptor antagonists
JP5237799B2 (ja) * 2005-06-27 2013-07-17 エグゼリクシス パテント カンパニー エルエルシー ピラゾールベースのlxrモジュレーター
CN101248048B (zh) * 2005-06-27 2013-08-28 埃克塞利希斯专利有限责任公司 吡唑基lxr调节剂
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
CN101679297B (zh) 2006-12-08 2012-01-11 埃克塞利希斯股份有限公司 Lxr和fxr调节剂
US7906544B2 (en) 2007-01-26 2011-03-15 North Carolina State University Inhibition of bacterial biofilms with imidazole derivatives
ES2424023T3 (es) 2007-10-18 2013-09-26 Janssen Pharmaceutica N.V. 1,2,4-triazoles trisustituidos
JO2784B1 (en) * 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
EP2224809A4 (en) 2007-11-27 2014-06-11 Univ North Carolina State INHIBITION OF BIOFILMS IN PLANTS WITH IMIDAZOLE DERIVATIVES
CA2714662C (en) 2008-03-19 2016-05-10 Janssen Pharmaceutica Nv Trisubstituted 1,2,4-triazoles as nicotinic acetylcholine receptor modulators
US9005643B2 (en) 2008-04-04 2015-04-14 North Carolina State University Inhibition of bacterial biofilms with imidazole-phenyl derivatives
WO2009131654A2 (en) 2008-04-21 2009-10-29 North Carolina State University Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
CL2009001125A1 (es) 2008-05-09 2011-02-11 Janssen Pharmaceutica Nv Compuestos derivados de pirazol trisustituido, moduladores alostericos positivos de los receptores ach nicotinicos; composicion farmaceutica que los comprende; proceso de preparacion de la composicion; y su uso en el tratamiento de enfermedades de snc o inflamatorias.
EP2321262A1 (de) * 2008-08-14 2011-05-18 Bayer CropScience AG Insektizide 4-phenyl-1h-pyrazole
WO2010077603A1 (en) 2008-12-08 2010-07-08 North Carolina State University Inhibition and dispersion of biofilms in plants with imidazole-triazole derivatives
WO2010144686A1 (en) 2009-06-10 2010-12-16 North Carolina State University Inhibition and dispersion of bacterial biofilms with benzimidazole derivatives
WO2011015524A2 (en) * 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
WO2011080132A2 (en) * 2009-12-17 2011-07-07 Katholieke Universiteit Leuven, K.U. Leuven R&D Compounds, compositions and methods for controlling biofilms
WO2012135016A2 (en) 2011-03-25 2012-10-04 North Carolina State University Inhibition of bacterial biofilms and microbial growth with imidazole derivatives
US20140010783A1 (en) * 2012-07-06 2014-01-09 Hoffmann-La Roche Inc. Antiviral compounds
CA2900826A1 (en) * 2013-03-05 2014-09-12 F. Hoffmann-La Roche Ag Antiviral compounds
EP2964635B1 (en) * 2013-03-06 2018-05-02 F.Hoffmann-La Roche Ag Antiviral compounds
EP3119394B1 (en) * 2014-03-19 2021-05-12 Curza Global LLC Compositions and methods comprising 2-(acylamino)imidazoles
WO2015191630A1 (en) 2014-06-10 2015-12-17 Sanford-Burnham Medical Research Institute Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof
WO2018184019A1 (en) 2017-03-31 2018-10-04 Curza Global, Llc Compositions and methods comprising substituted 2-aminoimidazoles
AR122450A1 (es) * 2020-05-08 2022-09-14 Lilly Co Eli Compuestos de (trifluorometil)pirimidin-2-amina
CN116410077A (zh) * 2023-04-14 2023-07-11 甘肃青宇新材料有限公司 一种2,4,6-三甲基苯甲酸的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE492033A (enExample) * 1948-11-05
GB696692A (en) * 1950-12-06 1953-09-09 Ici Ltd New quinazoline derivatives
US3464987A (en) * 1966-02-21 1969-09-02 Upjohn Co 1,2-dihydro-1-hydroxy-2-imino-6-(lower alkyl)pyrimidines
EP0658559A1 (de) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
CA2445003A1 (en) * 2001-05-16 2002-11-21 Boehringer Ingelheim Pharmaceuticals, Inc. Diarylurea derivatives useful as anti-inflammatory agents
GB0203412D0 (en) * 2002-02-13 2002-04-03 Pharmagene Lab Ltd 5-HT 2B receptor antagonists
WO2004009016A2 (en) * 2002-07-18 2004-01-29 Bristol-Myers Squibb Company Compositions and methods involving nuclear hormone receptor site ii
AU2003251970A1 (en) * 2002-07-18 2004-02-09 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
EP1566384B1 (en) * 2002-11-29 2009-06-17 Banyu Pharmaceutical Co., Ltd. Novel azole derivatives

Similar Documents

Publication Publication Date Title
JP2006528617A5 (enExample)
JP2009531376A5 (enExample)
JP2005537854A5 (enExample)
JP2009523760A5 (enExample)
JP2005506338A5 (enExample)
JP2012092103A5 (enExample)
JP2007502287A5 (enExample)
JP2007530577A5 (enExample)
JP2009526034A5 (enExample)
JP2011026326A5 (enExample)
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
JP2009533343A5 (enExample)
JP2008526999A5 (enExample)
JP2013514980A5 (enExample)
JP2014514349A5 (enExample)
JP2011500545A5 (enExample)
JP2011521911A5 (enExample)
JP2006526590A5 (enExample)
JP2009535462A5 (enExample)
JP2013542261A5 (enExample)
JP2013528180A5 (enExample)
JP2019515908A5 (enExample)
JP2008540554A5 (enExample)
JP2016503797A5 (enExample)
JP2011520903A5 (enExample)